Oxidative stress-related biomarkers in Parkinson's disease: A systematic review and meta-analysis

Zeba Khan, Sharique Athar Ali, Zeba Khan, Sharique Athar Ali

Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterized with the loss of dopamine-producing neurons in a mid-brain. This loss is believed to be associated with number of environmental and genetic factors. Oxidative stress is found to be one of the factors responsible for the initiation and progression of PD. However, studies are still continued to confirm the connection and mechanism associated with oxidative stress and PD. This systematic review and meta-analysis aimed to assess the association between oxidative stress markers and PD, and explore factors that may elucidate the contradictions in these results. As per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline systematic literature search was carried out. Meta-analysis was carried out on pooled standardized mean differences with 95% confidence interval (CI) of patients with PD and controls using random effect model in comprehensive meta-analysis statistical software. Total 17 studies were included into which 25 oxidative stress markers were analyzed. The results revealed that oxidative stress markers [nitrate and nitric oxide (NO)] and antioxidant markers [total antioxidant status (TAS) and thiols] were not statistically different between the PD and control group (P > 0.05). In case of oxidative stress markers, levels of malondialdehyde (MDA), 8-Oxo-2'-deoxyguanosine (8-oxo-dG), and lipid hydro-peroxide (LPO) were found to be high in patients with PD as compared to controls with P < 0.05, whereas lower levels of antioxidant activity of superoxide dismutase (SOD), glucose 6 phosphate dehydrogenase (G6PD), catalase (CAT), and glutathione peroxidase (GPx) were noticed in the PD group as compared to controls (P < 0.05 for all). From the results, it is concluded that patients with PD have high oxidative stress and lower antioxidant activity, and these studied biomarkers would be used as potential diagnostic tool to measure oxidative stress in patients with PD.

Keywords: Biomarkers; Meta-Analysis; Oxidative Stress; Parkinson’s Disease; Review.

Figures

Figure 1
Figure 1
Search strategy according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline flow diagram
Figure 2
Figure 2
Forest plot of meta-analysis of the relationship between oxidativemarkers and risk of Parkinson’s disease (PD)
Figure 3
Figure 3
Forest plot of meta-analysis of the relationship between antioxidant markers and risk of Parkinson’s disease (PD)

References

    1. Triarhou LC. Madame curie bioscience database [Internet] In: Triarhou LC, editor. Dopamine and Parkinson's disease. Austin, TX: Landes Bioscience; 2013.
    1. Brouwer M, Huss A, van der Mark M, Nijssen PCG, Mulleners WM, Sas AMG, et al. Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands. Environ Int. 2017;107:100–10.
    1. Cascianelli S, Tranfaglia C, Fravolini ML, Bianconi F, Minestrini M, Nuvoli S, et al. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using (123)I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT) Hell J Nucl Med. 2017;20(Suppl):165.
    1. Domingo A, Klein C. Genetics of Parkinson disease. Handb Clin Neurol. 2018;147:211–27.
    1. Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson's disease. Front Neuroanat. 2015;9:91.
    1. Hu Q, Wang G. Mitochondrial dysfunction in Parkinson's disease. Transl Neurodegener. 2016;5:14.
    1. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52(4):601–23.
    1. Umeno A, Biju V, Yoshida Y. In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes. Free Radic Res. 2017;51(4):413–27.
    1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–42.
    1. Oli RG, Fazeli G, Kuhn W, Walitza S, Gerlach M, Stopper H. No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: A pilot study. J Neural Transm (Vienna) 2010;117(6):737–46.
    1. Nikolova G, Mancheva V. Analysis of the parameters of oxidative stress in patients with Parkinson's disease. Comp Clin Path. 2013;22(2):151–5.
    1. Nikam S, Nikam P, Ahaley SK, Sontakke AV. Oxidative stress in Parkinson's disease. Indian J Clin Biochem. 2009;24(1):98–101.
    1. de Farias CC, Maes M, Bonifacio KL, Bortolasci CC, de Souza NA, Brinholi FF, et al. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets. Neurosci Lett. 2016;617:66–71.
    1. Agil A, Duran R, Barrero F, Morales B, Arauzo M, Alba F, et al. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa. J Neurol Sci. 2006;240(1-2):31–6.
    1. Sanyal J, Bandyopadhyay SK, Banerjee TK, Mukherjee SC, Chakraborty DP, Ray BC, et al. Plasma levels of lipid peroxides in patients with Parkinson's disease. Eur Rev Med Pharmacol Sci. 2009;13(2):129–32.
    1. Naduthota RM, Bharath RD, Jhunjhunwala K, Yadav R, Saini J, Christopher R, et al. Imaging biomarker correlates with oxidative stress in Parkinson's disease. Neurol India. 2017;65(2):263–8.
    1. Vinish M, Anand A, Prabhakar S. Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations. Acta Biochim Pol. 2011;58(2):165–9.
    1. Graciun EC, Dronca E, Leach NV. Antioxidant enzymes activity in subjects with Parkinson's disease under L-DOPA therapy. Human & Veterinary Medicine. 2016;8(2):124–7.
    1. Sanyal J, Sarkar BN, Banerjee TK, Mukherjee SC, Ray BC, Rao VR. Plasma level of nitrates in patients with Parkinson's disease in West Bengal. Neurol Asia. 2010;15(1):55–9.
    1. Kouti L, Noroozian M, Akhondzadeh S, Abdollahi M, Javadi MR, Faramarzi MA, et al. Nitric oxide and peroxynitrite serum levels in Parkinson's disease: Correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci. 2013;17(7):964–70.
    1. Tuncel D, Inanc Tolun F, Toru I. Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease. Mediators Inflamm. 2009;2009:132464.
    1. Abraham S, Soundararajan CC, Vivekanandhan S, Behari M. Erythrocyte antioxidant enzymes in Parkinson's disease. Indian J Med Res. 2005;121(2):111–5.
    1. Sudha K, Rao A, Rao S, Rao A. Free radical toxicity and antioxidants in Parkinson's disease. Neurol India. 2003;51:60–2.
    1. Verma AK, Raj J, Sharma V, Singh TB, Srivastava S, Srivastava R. Plasma prolidase activity and oxidative stress in patients with Parkinson's disease. Parkinsons Dis. 2015;2015:598028.
    1. Lin WC, Chou KH, Lee PL, Huang YC, Tsai NW, Chen HL, et al. Brain mediators of systemic oxidative stress on perceptual impairments in Parkinson's disease. J Transl Med. 2015;13:386.
    1. Adiga U, D'Souza J, Kousalya R, Rao GM, Nandini M, D'Souza V. Total antioxidant activity in Parkinson's disease. Biomedical Research. 2006;17(2):145–7.
    1. Woolley JF, Stanicka J, Cotter TG. Recent advances in reactive oxygen species measurement in biological systems. Trends Biochem Sci. 2013;38(11):556–65.
    1. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9–19.
    1. Sunday OP, Adekunle MF, Temitope OT, Richard AA, Samuel AA, Olufunminyi AJ, et al. Alteration in antioxidants level and lipid peroxidation of patients with neurodegenerative diseases {Alzheimer's disease and Parkinson disease} Int J Nutr Pharmacol Neurol Dis. 2014;4(3):146–52.
    1. Lu JM, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. J Cell Mol Med. 2010;14(4):840–60.
    1. Dhama K, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S. Oxidative stress, prooxidants, and antioxidants: The interplay. Biomed Res Int. 2014;2014:761264.
    1. Isobe C, Murata T, Sato C, Terayama Y. Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson disease. J Clin Neurosci. 2007;14(4):340–3.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel